Keyphrases
Nuclear factor-κB Pathway
100%
Dextran Sulfate Sodium-induced Colitis
100%
Lactobacillus Casei Shirota
100%
Taurine-conjugated Bile Acids
100%
Relative Abundance
15%
Inflammatory Bowel Disease
15%
Gut Microbiota Composition
15%
Dextran Sulfate Sodium
15%
Bile Acid Profile
15%
Muricholic Acid
15%
Nitric Oxide
7%
Intestine
7%
Suppression Effect
7%
Positive Impact
7%
Beneficial Effects
7%
Therapeutic Effect
7%
Inflammatory Mediators
7%
Interleukin-10
7%
Inflammatory Response
7%
Hydroxylated
7%
Bile Acids
7%
Physiological Condition
7%
Colon
7%
Interferon-γ
7%
Bacterial Species
7%
Pathological Conditions
7%
Evidence Support
7%
Clinical Manifestations
7%
Anti-inflammatory Effect
7%
Nuclear factor-κB
7%
Anti-inflammatory Mechanism
7%
Occludin
7%
Host Immune Response
7%
Intestinal Inflammation
7%
Bile Acid Metabolism
7%
Microbiological Analysis
7%
Chronic Progressive
7%
Fecal Microbiota
7%
Mouse Colitis
7%
Acute Colitis
7%
Intestinal Barrier Function
7%
Taurochenodeoxycholic Acid
7%
Pathobiont
7%
Tauroursodeoxycholic Acid (TUDCA)
7%
Intestinal Integrity
7%
Colitis
7%
Taurocholic Acid
7%
Taurodeoxycholic Acid
7%
MUC2
7%
Anti-inflammatory Mediators
7%
Gut Metabolites
7%
Colon Tissue
7%
Primary Bile Acid
7%
Circulating Bile Acid
7%
Pharmacology, Toxicology and Pharmaceutical Science
Lactobacillus casei
100%
Immunoglobulin Enhancer Binding Protein
100%
Bile Acid Conjugate
100%
Dextran Sulfate Sodium-Induced Colitis
100%
Bile Acid
38%
Intestine Flora
23%
Anti-Inflammatory Drug
15%
Inflammatory Bowel Disease
15%
Dextran Sulfate
15%
Colitis
15%
Mouse Model
7%
Taurochenodeoxycholic Acid
7%
Feces microflora
7%
Antiinflammatory Activity
7%
Inflammatory Disease
7%
Therapeutic Effect
7%
Taurodeoxycholic Acid
7%
Gamma Interferon
7%
Mucin 2
7%
Tauroursodeoxycholic Acid
7%
Inflammation
7%
Nitric Oxide
7%
Occludin
7%
Interleukin 10
7%
Taurocholic Acid
7%